Grief is defined as ‘the internal experience of a person to the loss of something loved and valued’. It is a normal and expected reaction to loss. While anticipatory grief is defined as ‘an emotional response that is experienced before a true loss’, a concept focusing on that a person might experience grief when the loss of a close loved one was anticipated, but had not yet occurred. The history of Abu Bakr r.a. was reviewed especially from the period of a few months before and recently after the death of the prophet s.a.w. It was noted that he appeared strong while others were down grieving upon the news of the prophet s.a.w.’s death. It was also noted that Abu Bakr r.a. has been grieving when he anticipated that the prophet was going to die. Literatures on anticipatory grief were reviewed. Evidence are conflicting on the role of anticipatory grief. Factors that lead to these differences will be reviewed. The protective factors in Abu Bakr r.a. that helped maintain his composure after the death of prophet Muhammad s.a.w. and later led him to be pledged as the first caliph of the Muslim nation will be discussed.
Randomized control trials (RCTs) are considered as most rigors way of determining the cause-effect relationship of a treatment and outcome. Activation of rennin angiotensin aldosterone system (RAAS) is an important contributor to hypertension in hemodialysis patients. The prevalence of hypertension in hemodialysis patients varies from 60% to 80% and hypertension management alone with conventional hemodialysis is insufficient. Hence, the current review was aimed to investigate the effect of RAAS inhibitors in managing hypertension among hemodialysis patients in a randomized control trial. Using PUBMED and EMBASE databases, randomized control trial with primary or secondary outcomes related to the effect of RAAS inhibitors on blood pressure among hemodialysis patients were included for analysis. The current review also assessed the quality of reporting of RCT. A total of eight RCT met inclusion criteria for current review. According to modified jaded scale, one (12.5%) study scored four points for quality reporting, whereas two (25%) studies scored one point that was the least score. The mean score for all included studies was 2.25. Six (75%) of the eight RCT included, involved ARB in hypertension management among hemodialysis patients, whereas two (25%) studies involved angiotensin-converting enzyme (ACE) inhibitors. Of the siz RCT involving ARB, two (33.3%) RCT also included ACE inhibitors comparison group. Altogether six (75%) studies report a reduction in blood pressure with the use of RAAS inhibitors compared to control group; however, of the six studies, two (33.3%) reported that the reduction in blood pressure was not significant. Whereas, two (25%) studies reported no reduction in blood pressure compared to the control group. The findings from current review do not indicate a clear pattern for a role of RAAS inhibitors for hypertension control among hemodialysis patients.
The assessment of nutritional status among paediatric patients is important for the planning and execution of nutritional strategies that strive to optimise the quality of life and growth among sick children. The present study aimed to evaluate the nutritional status and dietary intake among children with acute leukaemia.